EASTHAM KARIN

VCYT

EASTHAM KARIN serves as Director at Veracyte, Inc. (VCYT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$1.42M

Net Position

Net Seller

$1.42M

Companies Traded

VCYT

Active Period

Jun 2025 – Dec 2025

3 total trades

Most Recent

Sell VCYT

Dec 5, 2025 · $908.9K

EASTHAM KARIN's Insider Trading at Veracyte, Inc. (VCYT)

Buys

0 · $0.00

Sells

3 · $1.42M

Total Shares Bought

Total Shares Sold

34,264

VCYT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 5, 2025↗	Sell	20,000	$45.45	$908.9K
Nov 5, 2025↗	Sell	9,674	$40.02	$387.2K
Jun 13, 2025↗	Sell	4,590	$26.66	$122.4K

Related Insiders

Marc Stapley

director, officer: Chief Executive Officer

VCYTSell · Mar 4, 2026

Annie McGuire

officer: SVP, General Counsel

VCYTSell · Mar 4, 2026

Rebecca Chambers

officer: Chief Financial Officer

VCYTSell · Mar 4, 2026

John Leite

officer: Chief Commercial Officer-CLIA

VCYTSell · Mar 4, 2026

Phillip G. Febbo

officer: Chief Scientific & Med Officer

VCYTSell · Mar 2, 2026

Annie McGuire

SVP, General Counsel

VCYTSell · Dec 16, 2025

Marc Stapley

Chief Executive Officer

VCYTSell · Dec 4, 2025

John Leite

Chief Commercial Officer-CLIA

VCYTSell · Dec 4, 2025

Explore More Insider Trading Data

VCYT Insider Trading Activity

View all insider trades at Veracyte, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity